Core Viewpoint - The company reported its 2025 H1 financial results, showing slight growth in total revenue and net profit, while facing challenges in Q2 due to external policy restrictions. The management's strategic focus on market expansion and product structure optimization is expected to drive future growth [1][2]. Financial Performance - In 2025 H1, total revenue, net profit attributable to the parent, and net profit excluding non-recurring items were 1.76 billion, 300 million, and 290 million respectively, with year-on-year changes of +0.3%, +1.1%, and -4.1% [1]. - For Q2 2025, total revenue, net profit attributable to the parent, and net profit excluding non-recurring items were 650 million, 60 million, and 60 million respectively, with year-on-year changes of -4.0%, -12.8%, and -27.3% [1]. Product Structure and Market Development - The company achieved revenue of 380 million, 970 million, and 370 million from products priced above 300 yuan, between 100-300 yuan, and below 100 yuan respectively in 2025 H1, with year-on-year growth of +22%, +9%, and -30% [2]. - The proportion of products priced above 100 yuan in the liquor business increased by 8.9 percentage points to 78.7% [2]. - The company had 657 distributors in the provincial market by the end of Q2 2025, a net decrease of 56 compared to the end of 2024 [2]. Profitability and Efficiency - The gross margin for 2025 H1 increased by 0.5 percentage points to 65.6%, while Q2 saw a decrease of 1.0 percentage points to 63.7% due to increased costs [3]. - The sales expense ratio decreased by 0.2 percentage points to 19.0% in H1, while the management expense ratio decreased by 0.5 percentage points to 9.2% [3]. - The net profit margin for H1 was 17.0%, with a year-on-year increase of 0.1 percentage points, while Q2 saw a decrease to 9.9% [3]. Long-term Growth Potential - The company maintains a stable management team and a flexible "one area, one policy" mechanism, with sufficient financial support [3]. - The revenue forecast for 2025-2027 is adjusted to 3.03 billion, 3.17 billion, and 3.37 billion yuan, with year-on-year growth of +0.2%, +4.6%, and +6.3% respectively [3]. - The estimated EPS for 2025-2027 is 0.77, 0.81, and 0.86 yuan, with a target price of 22.92 yuan based on a 30x PE ratio for 2025 [3].